Cox A R, Marriott J F, Wilson K A, Ferner R E
West Midlands Centre for Adverse Drug Reaction Reporting, City Hospital NHS Trust, Birmingham, UK.
J Clin Pharm Ther. 2004 Feb;29(1):31-5. doi: 10.1046/j.1365-2710.2003.00533.x.
To assess the extent of teaching about the Committee on Safety of Medicine's Yellow Card scheme and adverse drug reactions within UK Schools of Medicine and Pharmacy.
A self-completed questionnaire sent to all heads of undergraduate schools of medicine and pharmacy within the UK.
The majority of undergraduate syllabi feature the Yellow Card Scheme. Knowledge of the Yellow Card Scheme was assessed in 79% of pharmacy programmes and 57% of medical schools. Specialist speakers on the Yellow Card Scheme were infrequently used. Fewer than half of respondents provided students with a guide to reporting ADRs (43% pharmacy and 43% medical). There is some disagreement about the value of supplying students with printed material about the Yellow Card Scheme. Half of medical Schools did not think that supplying 'Current Problems In Pharmacovigilance' would be useful.
It was found that in both medicine and pharmacy, courses differed substantially in teaching about the Yellow Card Scheme and adverse drug reactions (ADRs). There is scope for increased involvement of the Medicines and Healthcare products Regulatory Agency in undergraduate education, in line with recommendations from the National Audit Office.
评估英国医学院校和药学院校中关于药品安全委员会黄卡计划及药品不良反应的教学程度。
向英国所有本科医学院校和药学院校的负责人发送一份自填式问卷。
大多数本科教学大纲都包含黄卡计划。79%的药学专业课程和57%的医学院校评估了对黄卡计划的了解情况。很少有专业人士就黄卡计划进行授课。不到一半的受访者为学生提供药品不良反应报告指南（药学专业为43%，医学专业为43%）。对于向学生提供有关黄卡计划的印刷材料的价值存在一些分歧。一半的医学院校认为提供《药物警戒当前问题》没有用处。
研究发现，在医学和药学领域，关于黄卡计划和药品不良反应的课程教学存在很大差异。根据国家审计署的建议，药品和医疗产品监管局在本科教育中的参与度有提高的空间。
